NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-001-2016-0-IN-08 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS IN National Stage 201847016354 Abandoned
NCI E-247-2015-0-AU-03 SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA AU National Stage 2016335750 Issued
NIAID E-153-2015-0-US-03 Methods of Treating Cornonavirus Infection US National Stage 15/302,915 10434116 Issued PDF
NCI E-116-2014-0-US-04 Iodonium Analogs as Inhibitors of NADPH Oxidases and Other Flavin Dehydrogenases; Formulations Thereof; and Uses Thereof US National Stage 15/302,566 10131659 Issued PDF
NIAID E-145-2011-0-AU-10 Plasmodial Surface Anion Channel Inhibitors For The Treatment Or Prevention Of Malaria AU DIV 2016238979 Issued
NCI E-247-2015-0-PCT-02 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA PCT PCT PCT/US2016/055957 Expired
NCI E-247-2015-0-EP-05 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA EP National Stage 16784678.1 Pending
NCI E-247-2015-0-CA-04 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA CA National Stage 2997809 Pending
NCI E-227-2006-5-AU-11 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS AU DIV 2016238894 Issued
NCI E-263-2009-0-JP-10 Antiangiogenic Small Molecules and Methods of Use JP DIV 2016-198112 Abandoned
NCI E-148-2011-0-JP-11 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer JP DIV 198519/2016 Abandoned
NIAID E-279-2011-0-US-03 METHODS OF PRODUCING T CELL POPULATIONS ENRICHED FOR STABLE REGULATORY T-CELLS US DIV 15/284,840 11060059 Issued PDF
NIA E-139-2012-2-US-11 Methods of Regulating Cannabinoid Receptor Activity-Related Disorders and Diseases US CON 15/225,643 10130593 Issued PDF
NIAID E-540-2013-0-HK-07 METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION HK EP 16111480.6 Issued
NCI E-080-2014-0-US-03 ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY US National Stage 15/300,883 10556916 Issued PDF
NHLBI E-273-2015-0-PCT-02 Endo-cameral Closure Device PCT PCT PCT/US2016/054961 Expired
NHLBI E-165-2015-1-PCT-01 Lentiviral Protein Delivery System For RNA-guided Genome Editing PCT PCT COMB PCT/US16/054759 Expired
NCI E-208-2015-0-CA-04 Thalidomide Analogs and Methods of Use CA National Stage 3000661 Issued
NCI E-208-2015-0-AU-03 Thalidomide Analogs and Methods of Use AU National Stage 2016330967 Issued
NIAID E-057-2011-2-US-04 Virus Like Particles (VLPs) And Method Of Use US DIV 15/279,592 10138277 Issued PDF
NINDS E-024-2016-1-PCT-01 METHODS OF TREATING AND PREVENTING AMYOTRPHIC LATERAL SCLEROSIS (ALS) PCT PCT COMB PCT/US2016/054519 Expired
NCI E-208-2015-0-PCT-02 Thalidomide Analogs and Methods of Use PCT PCT PCT/US2016/054430 Expired
NCI E-208-2015-0-EP-05 Thalidomide Analogs and Methods of Use EP National Stage 16782148.7 Pending
NINDS E-024-2016-1-EP-02 METHODS OF TREATING AND PREVENTING AMYOTRPHIC LATERAL SCLEROSIS (ALS) EP National Stage 16781622.2 Abandoned
NCATS E-060-2017-3-PCT-01 Compositions And Methods For Identifying And Treating Dystonia Disorders PCT PCT COMB PCT/US16/054513 Expired
NHLBI E-124-2014-3-US-01 Device For Closure Of Transvascular Or Transcameral Access Ports US CIP 15/277,798 10058315 Issued PDF
NHLBI E-124-2014-4-US-01 Device For Closure Of Transvascular Or Transcameral Access Ports US CIP 15/277,805 Abandoned
NICHD E-042-2013-0-US-06 Injectable Dendrimer Hydrogel Nanoparticles US CON 15/277,877 Pending
NIDDK E-213-2015-0-CN-03 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS CN National Stage 201680064441.5 Issued
NCI E-278-2015-1-PCT-02 Human RPN2 Derived Peptides Useful for Treating Cancer PCT PCT PCT/US2016/053352 Abandoned
NIDDK E-213-2015-0-PCT-02 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS PCT PCT PCT/US16/053397 Expired
NIA E-013-2010-0-US-10 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS US CON 15/273,147 10130594 Issued PDF
CC E-088-2014-0-US-03 Conductive and Retrievable Devices US National Stage 15/127,974 Pending
NCATS E-235-2010-0-HK-07 Amido Compounds As RORvt Modulators And Uses Thereof HK EP 16111084.6 Pending
NCI E-176-2015-1-US-01 METHODS FOR DETECTING EXPRESSION OF LNC-FANCI-2 IN CERVICAL CELLS US ORD 15/270,774 10487365 Issued PDF
NIDDK E-761-2013-0-CN-03 cGAP-PNA Multivalent Peptide Nucleic Acid Ligand Display CN National Stage 201580015122.0 Abandoned
NCI E-264-2015-0-PCT-02 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE PCT PCT PCT/US2016/052496 Expired
NCI E-264-2015-0-EP-04 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE EP National Stage 16778536.9 Pending
NCI E-264-2015-0-EP-01 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE EP DIV Pending
NCI E-264-2015-0-CA-03 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE CA National Stage 2996205 Pending
NCI E-264-2015-0-FR-01 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE FR National Stage Pending
NCI E-264-2015-0-DE-01 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE DE National Stage Pending
NCI E-264-2015-0-GB-01 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE GB National Stage Pending
NCI E-105-2012-0-US-10 MURINE ANTI-NY-ESO-1 T CELL RECEPTORS US CON 15/267,285 10087230 Issued PDF
NIAID E-065-2018-0-CA-05 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF CA National Stage 2981191 Pending
NHLBI E-287-2015-0-US-02 Devices And Methods For Effectuating Percutaneous Glenn And Fontan Procedures US ORD 15/267,075 10426482 Issued PDF
NCATS E-020-2016-0-US-07 Antifungal Compound Process US National Stage 15/126,392 10399943 Issued PDF
NCATS E-021-2016-0-US-14 Antifungal Compound Process US National Stage 15/126,402 10173998 Issued PDF
NCATS E-023-2016-0-US-07 Antifungal Compound Process US National Stage 15/126,420 10017494 Issued PDF
NCATS E-022-2016-0-US-07 Antifungal Compound Process US National Stage 15/126,412 10000465 Issued PDF